Mark L. Berch

Array ( [id] => 7207017 [patent_doc_number] => 20050043329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Crystalline forms of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/791451 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11792 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043329.pdf [firstpage_image] =>[orig_patent_app_number] => 10791451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265063 [patent_doc_number] => 20040242599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases' [patent_app_type] => new [patent_app_number] => 10/786324 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4912 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242599.pdf [firstpage_image] =>[orig_patent_app_number] => 10786324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265020 [patent_doc_number] => 20040242556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Novel crystalline form of cefdinir' [patent_app_type] => new [patent_app_number] => 10/634978 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2469 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242556.pdf [firstpage_image] =>[orig_patent_app_number] => 10634978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369897 [patent_doc_number] => 07476670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Purine derivatives, method for preparing, pharmaceutical compositions and novel use' [patent_app_type] => utility [patent_app_number] => 10/780018 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23601 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476670.pdf [firstpage_image] =>[orig_patent_app_number] => 10780018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7437916 [patent_doc_number] => 20040267008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Process and ester derivatives useful for preparation of cephalosporins' [patent_app_type] => new [patent_app_number] => 10/781158 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11765 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20040267008.pdf [firstpage_image] =>[orig_patent_app_number] => 10781158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505562 [patent_doc_number] => 07202252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'A1 adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/780296 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8597 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202252.pdf [firstpage_image] =>[orig_patent_app_number] => 10780296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7128075 [patent_doc_number] => 20050059819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Cefdinir pyridine salt' [patent_app_type] => utility [patent_app_number] => 10/778851 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2799 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059819.pdf [firstpage_image] =>[orig_patent_app_number] => 10778851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468105 [patent_doc_number] => 20040198973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Process for preparation of carbapenem antibiotics' [patent_app_type] => new [patent_app_number] => 10/486789 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198973.pdf [firstpage_image] =>[orig_patent_app_number] => 10486789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428707 [patent_doc_number] => 07268141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Xanthine phosphodiesterase V inhibitors' [patent_app_type] => utility [patent_app_number] => 10/777849 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15146 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268141.pdf [firstpage_image] =>[orig_patent_app_number] => 10777849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859864 [patent_doc_number] => 20060229285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Crystal of intermediate for carbapenem' [patent_app_type] => utility [patent_app_number] => 10/542810 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5993 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229285.pdf [firstpage_image] =>[orig_patent_app_number] => 10542810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347234 [patent_doc_number] => 20040192708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Sulfonamide substituted xanthine derivatives' [patent_app_type] => new [patent_app_number] => 10/776697 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27318 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192708.pdf [firstpage_image] =>[orig_patent_app_number] => 10776697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469927 [patent_doc_number] => 20040167327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Coupling process and intermediates useful for preparing cephalosporins' [patent_app_type] => new [patent_app_number] => 10/776795 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10249 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167327.pdf [firstpage_image] =>[orig_patent_app_number] => 10776795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844413 [patent_doc_number] => 20060122164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Carboxylic acid esters of pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 10/541017 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11964 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122164.pdf [firstpage_image] =>[orig_patent_app_number] => 10541017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291209 [patent_doc_number] => 20040110775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Cyclin dependent kinase inhibiting purine derivatives' [patent_app_type] => new [patent_app_number] => 10/466693 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14293 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110775.pdf [firstpage_image] =>[orig_patent_app_number] => 10466693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662332 [patent_doc_number] => 20060252928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Process for the preparation of cefoxitin' [patent_app_type] => utility [patent_app_number] => 10/548888 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1780 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252928.pdf [firstpage_image] =>[orig_patent_app_number] => 10548888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672871 [patent_doc_number] => 20040180908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Adenosine derivative in polymorph ii form' [patent_app_type] => new [patent_app_number] => 10/481612 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1744 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180908.pdf [firstpage_image] =>[orig_patent_app_number] => 10481612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217169 [patent_doc_number] => 07612079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => '2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders' [patent_app_type] => utility [patent_app_number] => 10/742237 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24072 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612079.pdf [firstpage_image] =>[orig_patent_app_number] => 10742237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939598 [patent_doc_number] => 20080076917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof' [patent_app_type] => utility [patent_app_number] => 10/538466 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31781 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076917.pdf [firstpage_image] =>[orig_patent_app_number] => 10538466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348202 [patent_doc_number] => 20040192912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one' [patent_app_type] => new [patent_app_number] => 10/734012 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32617 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192912.pdf [firstpage_image] =>[orig_patent_app_number] => 10734012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859921 [patent_doc_number] => 20060229322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Anhydrous crystalline form of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/537989 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2793 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229322.pdf [firstpage_image] =>[orig_patent_app_number] => 10537989 [rel_patent_id] =>[rel_patent_doc_number] =>)